Diferencias y controversias entre el reporte de patología y la interpretación clínica en patología tiroidea. II PARTE: Aspectos patológicos y métodos diagnósticos con impacto terapéutico

Autores/as

  • Alfredo Ernesto Romero Instituto Nacional de Cancerología
  • Rafael Parra Medina Fundación Universitaria de Ciencias de la Salud
  • Sandra Isabel Chinchilla Olaya Instituto Nacional de Cancerología
  • Amelia de los Reyes Victoria Instituto Nacional de Cancerología
  • Augusto Llamas Olier Instituto Nacional de Cancerología

DOI:

https://doi.org/10.35509/01239015.190

Palabras clave:

Tiroides, Biopsia con aguja, Secciones por congelación, Inmunohistoquímica, Tomografía por emisión de positrones/tomografía computarizada

Resumen

Como revisamos en la primera parte 1 hay algunos conceptos que deben ser considerados para el adecuado manejo médico por parte del equipo clínico que recibe el reporte de patología, de esta misma manera existen aspectos por parte del patólogo que este debe conocer, los cuales tienen impacto terapéutico.
En esta segunda parte queremos revisar algunos conceptos que son de importancia por parte del patólogo que aplican directamente sobre la interpretación del clínico, como: procesamiento macroscópico; estudio de la citología por aspiración con aguja fina (FNA) vs. biopsia trucut, utilidad de la biopsia por congelación y de la inmunohistoquímica, así como los métodos e imágenes diagnósticas.

Biografía del autor/a

Alfredo Ernesto Romero, Instituto Nacional de Cancerología

Grupo Patología Oncológica, Instituto Nacional de Cancerología, Bogotá D. C., Colombia

Rafael Parra Medina, Fundación Universitaria de Ciencias de la Salud

Grupo de Patología y epidemiología, Fundación Universitaria de Ciencias de la Salud, Bogotá D. C., Colombia

Sandra Isabel Chinchilla Olaya, Instituto Nacional de Cancerología

Grupo Patología Oncológica, Instituto Nacional de Cancerología, Bogotá D. C., Colombia

Amelia de los Reyes Victoria, Instituto Nacional de Cancerología

Grupo Medicina Nuclear, Instituto Nacional de Cancerología, Bogotá D. C., Colombia

Augusto Llamas Olier, Instituto Nacional de Cancerología

Grupo Medicina Nuclear, Instituto Nacional de Cancerología, Bogotá D. C., Colombia

Referencias bibliográficas

Romero Rojas AE, Parra Medina R, Chinchilla Olaya SI, De Los Reyes Victoria A, Llamas Olier A. Diferencias y controversias . entre el reporte de patología y la interpretación clínica en patología tiroidea. I parte: Factores pronósticos. Rev Colomb Cancerol. 2016, http://dx.doi.org/10.1016/j.rccan.2016.07.002 [Epub ahead of print].

https://doi.org/10.1016/j.rccan.2016.07.002

Rosai J. Rosai and Ackerman's Surgical Pathology. 10th Edition. Mosby; 2011.

Allen DC, Cameron RI. Histopathology Specimens Clinical, Pathological and Laboratory Aspects. Second. 2012.

Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214.

https://doi.org/10.1089/thy.2009.0110

Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiate Thyroid Cancer: What is new and what has changed? Cancer. 2016, http://dx.doi.org/10.1002/cncr.30360 [Epub ahead of print].

https://doi.org/10.1002/cncr.30360

Layfield LJ, Cibas ES, Baloch Z. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology. 2010;21:75-85.

https://doi.org/10.1111/j.1365-2303.2010.00750.x

Belfiore A, La Rosa G. Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am. 2001;30:361-400.

https://doi.org/10.1016/S0889-8529(05)70191-2

Screaton NJ, Berman LH, Grant JW. US-guided core-needle biopsy of the thyroid gland. Radiology. 2003;226:827-32.

https://doi.org/10.1148/radiol.2263012073

Vallejo KM, Triana G, Romero J, García A, Santamaría A. Aspiración con aguja fina y biopsia con aguja trucut simultáneas para el diagnóstico de nódulos tiroideos: concordancia y rendimiento diagnóstico. Rev Colomb Radiol. 2009;20:2557-63.

Rosai J, DeLellis R, Carcangiu M, Frable W, Tallini G. Tumors of the Thyroid and Parathyroid Glands (AFIP Atlas of Tumor Pathology). American Registry of Pathology. 2015.

Boey J, Hsu C, Wong J, Ong GB. Fine-needle aspiration versus drill-needle biopsy of thyroid nodules: a controlled clinical trial. Surgery. 1982;91:611-5.

Carlosama Rosero Y, Reyes Gutierrez N, Rolon MC, Rosero EA. Biopsia por congelación: recomendaciones en la práctica clínica y dermatológica. Rev Colomb Cancerol. 2014;18:88-91.

https://doi.org/10.1016/j.rccan.2014.03.002

Wilson L. A method for the rapid preparation of fresh tissues for the microscope. JAMA. 1905;45:1737.

https://doi.org/10.1001/jama.1905.52510230037003c

Delgado J. Realidad en biopsias por congelación. Univ Médica. 2007;48:37-45.

Zarbo RJ, Schmidt WA, Bachner P, Howanitz PJ, Meier FA, Schifman RB, et al. Indications and inmediate patient outcome of pathology intraoperative consultations: A College of American Pathologist/Centers for disease contral and prevention outcomes Working Group Study. Arch Pathol Lab Med. 1996;120:19-25.

McHenry CR, Raeburn C, Strickland T, Marty JJ. The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg. 1996;172:658-61.

https://doi.org/10.1016/S0002-9610(96)00302-9

Mayooran N, Waters PS, Kaim Khani TY, Kerin MJ, Quill D. FNAC and frozen section correlations with definitive histology in thyroid diseases. Eur Arch Otorhinolaryngol. 2015. Epub ahead.

https://doi.org/10.1530/endoabs.37.EP841

Cibas E, Ali S. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19:1159-65.

https://doi.org/10.1089/thy.2009.0274

LiVolsi Va, Baloch ZW. Use and abuse of frozen section in the diagnosis of follicular thyroid lesions. Endocr Pathol. 2005;16:285-93.20. Chen H, Nicol TL, Udelsman R. Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg. 1995;222:101-6.

https://doi.org/10.1097/00000658-199507000-00016

Jozaghi Y, Richardson K, Anand S, Mlynarek A, Hier MP, Forest VI, et al. Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer. J Otolaryngol Head Neck Surg. 2013;42:48.

https://doi.org/10.1186/1916-0216-42-48

Park YM, Wang SG, Goh JY, Shin DH, Kim IJ, Lee BJ. Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer. World J Surg. 2015;39:187-93.

https://doi.org/10.1007/s00268-014-2795-5

Bando T, Genka K, Ishikawa K, Kuniyoshi M, Kuda T. Ectopic intrapulmonary thyroid. Chest. 1993;103:1278-9.

https://doi.org/10.1378/chest.103.4.1278

Harach HR. Ectopic thyroid tissue adjacent to the gallbladder. Histopathology. 1998;32:90-1.

https://doi.org/10.1046/j.1365-2559.1998.0241g.x

Mysorekar VV, Dandekar CP, Sreevathsa MR. Ectopic thyroid tissue in the parotid salivary gland. Singapore Med J. 2004;45:437-8.

Ruchti C, Balli-Antunes M, Gerber HA. Follicular tumor in the sellar region without primary cancer of the thyroid. Heterotopic carcinoma? Am J Clin Pathol. 1987;87:776-80.

https://doi.org/10.1093/ajcp/87.6.776

Romero Rojas A, Bella Cueto MR, Meza Cabrera Ia, Cabezuelo Hernández A, García Rojo D, Vargas Uricoechea H, et al. Ectopic thyroid tissue in the adrenal gland: a report of two cases with pathogenetic implications. Thyroid. 2013;23:1644-50.

https://doi.org/10.1089/thy.2013.0063

LiVolsi V. Surgical Pathology of the Thyroid. 1990.

Meyerowitz BR, Buchholz RB. Midline cervical ectopic thyroid tissue. Surgery. 1969;65:358-62.

Gerard Marchant R, Caillou B. Thyroid inclusions in cervical lymph nodes. Clin Endocrinol Metab. 1981;10:337-49.

https://doi.org/10.1016/S0300-595X(81)80026-6

Kakudo K, Shan L, Nakamura Y, Inoue D, Koshiyama H, Sato H. Clonal analysis helps to differentiate aberrant thyroid tissue from thyroid carcinoma. Hum Pathol. 1998;29:187-90.

https://doi.org/10.1016/S0046-8177(98)90232-5

Nikiforov Y, Biddinger P, Thompson L. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2012.

Papi G, Fadda G, Corsello SM, Corrado S, Rossi ED, Radighieri E, et al. Metastases to the thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience. Clin Endocrinol (Oxf). 2007;66:565-71.

https://doi.org/10.1111/j.1365-2265.2007.02773.x

Lin JD, Weng HF, Ho YS. Clinical and pathological characteristics of secondary thyroid cancer. Thyroid. 1998;8:149-53.

https://doi.org/10.1089/thy.1998.8.149

Caballero Casta˜neda D, Romero Rojas A, Parra Medina R. «Tumor to tumor metástasis». Un evento poco frecuente. A propósito de un carcinoma renal metastásico a un carcinoma papilar de tiroides. Rev Esp Patol. 2016 Article in press available online. August 2016 DOI: 10.1016/j.patol.2016.07.002.

https://doi.org/10.1016/j.patol.2016.07.002

Yeo SJ, Kim KJ, Kim BY, Jung CH, Lee SW, Kwak JJ, et al. Metastasis of colon cancer to medullary thyroid carcinoma: a case report. J Korean Med Sci. 2014;29:1432-5.

https://doi.org/10.3346/jkms.2014.29.10.1432

Bohn OL, De las Casas LE, Leon ME. Tumor-to-tumor metastasis: Renal cell carcinoma metastatic to papillary carcinoma of thyroid-report of a case and review of the literature. Head Neck Pathol. 2009;3:327-30.

https://doi.org/10.1007/s12105-009-0147-9

Choi SH, Baek JH, Ha EJ, Choi YJ, Song DE, Kim JK, et al. Diagnosis of Metastasis to the Thyroid Gland: Comparison of Core-Needle Biopsy and Fine-Needle Aspiration. Otolaryngol Head Neck Surg. 2016 [Epub ahead of print].

https://doi.org/10.1177/0194599816629632

Fadare O, Parkash V, Fiedler PN, Mayerson AB, Asiyanbola B. Tumor-to-tumor metastasis to a thyroid follicular adenoma as the initial presentation of a colonic adenocarcinoma. Pathol Int. 2005;55:574-9.

https://doi.org/10.1111/j.1440-1827.2005.01871.x

Dund-erovi'c D, Lipkovski JM, Boriˇcic I, Soldatovi'c I, Boˇzic V, Cveji'c D, et al. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature. Diagn Pathol. 2015;10:196.

https://doi.org/10.1186/s13000-015-0428-4

Nam JK, Jung CK, Song BJ, Lim DJ, Chae BJ, Lee NS, et al. Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Am J Surg. 2012;203:436-41.

https://doi.org/10.1016/j.amjsurg.2011.02.013

Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab. 2008;93:3943-9.

https://doi.org/10.1210/jc.2008-0607

Li C, Aragon Han P, Lee KC, Lee LC, Fox AC, Beninato T, et al. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers. J Clin Endocrinol Metab. 2013;98:3702-12.

https://doi.org/10.1210/jc.2013-1584

Soares P, Celestino R, Melo M, Fonseca E, Sobrinho Simões M. Prognostic biomarkers in thyroid cancer. Virchows Arch. 2014;464:333-46.

https://doi.org/10.1007/s00428-013-1521-2

Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, et al. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol. 2013;20:47-52.

https://doi.org/10.1245/s10434-012-2611-0

Marcus C, Whitworth PW, Surasi DS, Subramaniam RM. PET/CT in the management of Thyroid cancers. Am J Radiol. 2014;202:1316-29.

https://doi.org/10.2214/AJR.13.11673

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated Thyroid cancer. Thyroid. 2016;26:1-133.

https://doi.org/10.1089/thy.2015.0020

Leboulleux S, Schroeder PR, Schlumberger M, Ladenson PW. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers. Nat Clin Pract Endocrinol Metab. 2007;3:112-21.

https://doi.org/10.1038/ncpendmet0402

Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW, et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498-505.

https://doi.org/10.1210/jc.2005-1534

Deandreis D, Al Ghuzlan A, Leboulleux S, Lacroix L, Garsi JP, Talbot M, et al. Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? Endocr Relat Cancer. 2011;18:159-69.

https://doi.org/10.1677/ERC-10-0233

Leboulleux S, Schroeder PR, Busaidy NL, Auperin A, Corone C, Jacene HA, et al. Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-fluoro- 2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer. J Clin Endocrinol Metab. 2009;94:1310-6.

https://doi.org/10.1210/jc.2008-1747

Cómo citar

[1]
Romero, A.E. , Parra Medina, R. , Chinchilla Olaya, S.I. , de los Reyes Victoria, A. y Llamas Olier, A. 2017. Diferencias y controversias entre el reporte de patología y la interpretación clínica en patología tiroidea. II PARTE: Aspectos patológicos y métodos diagnósticos con impacto terapéutico. Revista Colombiana de Cancerología. 21, 3 (sep. 2017), 166–172. DOI:https://doi.org/10.35509/01239015.190.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2017-09-01

Número

Sección

Artículos de revisión